Roche Holding AG

Roche Holding AG is a prominent global healthcare holding company, specializing in pharmaceuticals and diagnostics. Headquartered in Basel, Switzerland and founded in 1896, Roche has grown to become one of the world's largest pharmaceutical companies, recognized especially for its leadership in cancer treatments and status as a major spender in pharmaceutical research and development. The group operates through two main divisions: Pharmaceuticals, focusing on innovative medicines for oncology, virology, and metabolic diseases, and Diagnostics, providing cutting-edge tests and technologies that advance patient care. Roche integrates scientific innovation with a commitment to preventing, diagnosing, and curing diseases with significant societal impact. The company’s large global footprint, robust product pipeline, and strategic acquisitions—including major stakes in Genentech and Chugai Pharmaceuticals—underscore its central role in shaping healthcare outcomes worldwide. Roche Holding AG is also notable for its long-standing dedication to sustainability, corporate responsibility, and steadily increasing shareholder dividends, making it a key player in both the healthcare and financial sectors.